KCM
AGN

Kornitzer Capital Management’s Allergan Inc AGN Stock Holding History

Kornitzer Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-129,471
Closed -$27.5M – 465
2014
Q4 		$27.5M Sell
129,471
-58,542
-31% -$11.6M 0.32% 101
2014
Q3 		$33.5M Sell
188,013
-5,800
-3% -$963K 0.38% 89
2014
Q2 		$32.8M Sell
193,813
-68,141
-26% -$10.6M 0.35% 94
2014
Q1 		$32.5M Buy
261,954
+6,350
+2% +$773K 0.34% 94
2013
Q4 		$28.4M Buy
255,604
+42,850
+20% +$4.09M 0.3% 99
2013
Q3 		$19.2M Sell
212,754
-50
-0% -$4.49K 0.23% 121
2013
Q2 		$17.9M Buy
+212,804
New +$22.1M 0.23% 125

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Kornitzer Capital Management's AGN Position: Q1 2015 in Review

Kornitzer Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 129,471 shares — an estimated $27.5M sold.

Kornitzer Capital Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $33.5M in Q3 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Kornitzer Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Kornitzer Capital Management sold 129,471 Allergan Inc shares in Q1 2015, an estimated $27.5M.
  • Kornitzer Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Kornitzer Capital Management's Allergan Inc position peaked at $33.5M in Q3 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Kornitzer Capital Management's 13F filing for Q1 2015, filed 1 May 2015.